Here is the synopsis of our sample research paper on Glaxo Welcome; a Financial Appraisal. Have the paper e-mailed to you 24/7/365.
Essay / Research Paper Abstract
This 5 page paper considers the position of a company though the picture presented by its’ annual accounts. The current financial strategy is considered and evaluated. The Bibliography cites 3 sources.
Page Count:
5 pages (~225 words per page)
File: TS14_TEglaxow.rtf
Buy This Term Paper »
Unformatted sample text from the term paper:
paperwriters.com/aftersale.htm Glaxo Welcome is an established and well known pharmaceutical company. The integration of Glaxo and Welcome in May 1995, created the worlds largest pharmaceutical company with combined
sales of ?6.5 billion (expert/glaxo.html, 1998). The business environment in which they have operated over the past 30 years has had very favorable market conditions (expert/glaxo.html). These condition have
been determined to three factors; the increasing demand and support for improved healthcare, investment in the industry as a whole has been high and technological advances have been beneficial, and
thirdly the weak links between the individuals who prescribe and use, and those who pay (usually the government) (expert/glaxo.html). This trend has been remained continuous until the last few years.
Although the link remains fairly weak the payers are becoming more active in determining what may or may not be prescribed in an effort to curb costs. As a result
the industry, including Glaxo Welcome has begun to suffer from demand-side constraints on their sales (expert/glaxo.html, 1998). This has further resulted in a downward pressure on prices. In conjunction
to this innovation is become relatively more expensive. Consequently the business has had to undergo radical adjustments in direction to change with this changing environment. Glaxos strengths lie within the
respiratory business with is playing an increasingly important role within the world wide business. Respiratory products currently account for 27% of their business (Glaxo nvestors/fr_investors.html). The sales currently stand at
?2.2 billion and growing. To put this into perspective the industry average growth in this area is 5%,but Glaxo Welcome currently is growing at a rate of 24% (Glaxo Welcome,
1998). The reason for these area of increase were seen as Glaxo Welcomes superiority in an area which is growing itself with continued increases in respiratory problems such as
...